Successful treatment of pulmonary hypertension due to HIV infection and amphetamine snorting: a case report
Open Access
- 23 April 2025
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1556041
Abstract
HIV infection is one of the high-risk factors for pulmonary hypertension (PH). HIV-related PH is associated with non-AIDS-related comorbidities. In this study, we report a case of pulmonary hypertension with several concomitant risk factors who experienced a complete clinical improvement after drug rehabilitation, application of anti-retroviral therapy (ART), and sildenafil. A 37-year-old HIV-positive man complained about worsening dyspnea was diagnosed with severe PH. PH in this case was characterized by association with multi-factors, including amphetamine inhalation, HIV infection, bacterial liver abscess, history of splenectomy, and past ventricular septal defect, which was different from previously reported HIV-related PH cases who were associated solely with HIV infection. Our case intends to raise awareness that PH should be suspected among HIV-positive patients with unexplained dyspnea. It is notable that investigating the coexistent risk factors and a multidisciplinary team are crucial for early diagnosis and better prognosis of HIV-related PH.Keywords
This publication has 23 references indexed in Scilit:
- Methamphetamine-associated pulmonary arterial hypertensionCurrent Opinion in Pulmonary Medicine, 2022
- Management and prognosis of HIV‐associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registryJournal of Internal Medicine, 2022
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Heart Journal, 2015
- Splenectomy Is Modifying the Vascular Remodeling of ThrombosisJournal of the American Heart Association, 2014
- HIV and pulmonary arterial hypertension: a systematic reviewHIV Medicine, 2010
- Increased procoagulant cell-derived microparticles (C-MP) in splenectomized patients with ITPThrombosis Research, 2008
- Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2 -Deficient MiceCirculation Research, 2006
- Sildenafil in HIV-related pulmonary hypertensionAIDS, 2001
- Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related CompoundsMolecular Pharmacology, 1999
- Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.Circulation, 1994